Moshe Papa

Medicine & Life Sciences

1. B72.3 antibody 15%
2. BRCA1 Gene 20%
3. BRCA2 Gene 13%
4. Breast 41%
5. Breast Neoplasms 100%
6. Carcinoid Tumor 10%
7. Cell Line 17%
8. Chemoprevention 10%
9. Colonic Neoplasms 35%
10. Cyclophosphamide 11%
11. Doxorubicin 12%
12. Drug Therapy 25%
13. Extracellular Matrix 21%
14. Familial Breast Cancer 22%
15. Gastrectomy 14%
16. Germ-Line Mutation 24%
17. Growth Factor Receptors 13%
18. Haplotypes 18%
19. Hemorrhage 10%
20. Hepatocytes 18%
21. Hypothyroidism 19%
22. IGF Type 1 Receptor 11%
23. Insulin Receptor Substrate Proteins 12%
24. Insulin-Like Growth Factor I 11%
25. Intercellular Signaling Peptides and Proteins 15%
26. Interleukin-2 25%
27. Israel 16%
28. Jews 25%
29. Liver 27%
30. Lymphokine-Activated Killer Cells 27%
31. Magnetic Resonance Spectroscopy 13%
32. Melanoma 16%
33. Morbidity 10%
34. Mutation 37%
35. Neoplasm Metastasis 14%
36. Neoplasms 41%
37. Ovarian Neoplasms 33%
38. Pelvic Floor 11%
39. Perfusion 11%
40. Phosphorylation 13%
41. Prophylactic Mastectomy 14%
42. Rectal Neoplasms 14%
43. Segmental Mastectomy 26%
44. Sp1 Transcription Factor 13%
45. Therapeutics 11%
46. Thioacetamide 13%
47. Thromboangiitis Obliterans 35%
48. Troleandomycin 10%
49. Tumor Necrosis Factor-alpha 12%
50. Tyrosine 13%